What advice would be appropriate for an asthma patient concerned about COVID-19 exposure?

Using inhaled corticosteroids is indeed safe for asthma management, particularly for patients who are concerned about COVID-19 exposure. Inhaled corticosteroids are a cornerstone treatment for asthma and help to control inflammation in the airways, reducing the frequency and severity of asthma symptoms.

Studies indicate that properly managed asthma patients, including those who are using inhaled corticosteroids, do not appear to be at heightened risk for severe outcomes from COVID-19 compared to non-asthmatic individuals. Maintaining asthma control is crucial during the pandemic, as poorly managed asthma can potentially lead to more severe respiratory complications, which could complicate any COVID-19 illness.

Discontinuing inhaled corticosteroids or avoiding all inhaled medications could increase the risk of asthma exacerbations, leading to potentially serious respiratory issues. Vaccination is important and can be recommended alongside inhaler use, but it does not require stopping asthma medications. Thus, it is not accurate to suggest that one should avoid inhaled medications or needs to get vaccinated before using any asthma management medication.

Therefore, reinforcing the use of inhaled corticosteroids as safe and effective while continuing to follow public health guidelines on COVID-19 shows a proper understanding of asthma management during this time.